Close Menu

The Wall Street Journal reports that Genomic Health has developed the Oncotype DX colon-cancer test, a genetic screen "that can predict whether patients treated for early-stage colon cancer are likely to suffer a recurrence of the disease," according to the story. A validation study of the test was presented in advance of the American Society of Clinical Oncology annual meeting.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.